GLP-1 receptor agonists, once considered a niche treatment primarily for type 2 diabetes, are rapidly becoming a mainstream option for…
Read More
U.S. Adult Obesity Rate Edges Down as Use of Weight-Loss Drugs Grows
For the first time in years, a meaningful drop in U.S. adult obesity has been recorded—and it appears to be…
Read More
